The clinical sequelae of intravascular hemolysis and extracellular plasma hemoglobin: a novel mechanism of human disease
- PMID:15811985
- DOI: 10.1001/jama.293.13.1653
The clinical sequelae of intravascular hemolysis and extracellular plasma hemoglobin: a novel mechanism of human disease
Abstract
Context: The efficient sequestration of hemoglobin by the red blood cell membrane and the presence of multiple hemoglobin clearance mechanisms suggest a critical need to prevent the buildup of this molecule in the plasma. A growing list of clinical manifestations attributed to hemoglobin release in a variety of acquired and iatrogenic hemolytic disorders suggests that hemolysis and hemoglobinemia should be considered as a novel mechanism of human disease.
Evidence acquisition: Pertinent scientific literature databases and references were searched through October 2004 using terms that encompassed various aspects of hemolysis, hemoglobin preparations, clinical symptoms associated with plasma hemoglobin, nitric oxide in hemolysis, anemia, pulmonary hypertension, paroxysmal nocturnal hemoglobinuria, and sickle-cell disease.
Evidence synthesis: Hemoglobin is released into the plasma from the erythrocyte during intravascular hemolysis in hereditary, acquired, and iatrogenic hemolytic conditions. When the capacity of protective hemoglobin-scavenging mechanisms has been saturated, levels of cell-free hemoglobin increase in the plasma, resulting in the consumption of nitric oxide and clinical sequelae. Nitric oxide plays a major role in vascular homeostasis and has been shown to be a critical regulator of basal and stress-mediated smooth muscle relaxation and vasomotor tone, endothelial adhesion molecule expression, and platelet activation and aggregation. Thus, clinical consequences of excessive cell-free plasma hemoglobin levels during intravascular hemolysis or the administration of hemoglobin preparations include dystonias involving the gastrointestinal, cardiovascular, pulmonary, and urogenital systems, as well as clotting disorders. Many of the clinical sequelae of intravascular hemolysis in a prototypic hemolytic disease, paroxysmal nocturnal hemoglobinuria, are readily explained by hemoglobin-mediated nitric oxide scavenging.
Conclusion: A growing body of evidence supports the existence of a novel mechanism of human disease, namely, hemolysis-associated smooth muscle dystonia, vasculopathy, and endothelial dysfunction.
Similar articles
- [Pathophysiological consequences of hemolysis. Role of cell-free hemoglobin].Misztal T, Tomasiak M.Misztal T, et al.Postepy Hig Med Dosw (Online). 2011 Sep 28;65:627-39. doi: 10.5604/17322693.961007.Postepy Hig Med Dosw (Online). 2011.PMID:22100795Review.Polish.
- The biochemistry of nitric oxide, nitrite, and hemoglobin: role in blood flow regulation.Gladwin MT, Crawford JH, Patel RP.Gladwin MT, et al.Free Radic Biol Med. 2004 Mar 15;36(6):707-17. doi: 10.1016/j.freeradbiomed.2003.11.032.Free Radic Biol Med. 2004.PMID:14990351Review.
- Role of the red blood cell in nitric oxide homeostasis and hypoxic vasodilation.Gladwin MT.Gladwin MT.Adv Exp Med Biol. 2006;588:189-205. doi: 10.1007/978-0-387-34817-9_17.Adv Exp Med Biol. 2006.PMID:17089890Review.
- Sickle cell disease vasculopathy: a state of nitric oxide resistance.Wood KC, Hsu LL, Gladwin MT.Wood KC, et al.Free Radic Biol Med. 2008 Apr 15;44(8):1506-28. doi: 10.1016/j.freeradbiomed.2008.01.008. Epub 2008 Jan 26.Free Radic Biol Med. 2008.PMID:18261470Review.
- Sickle cell anemia and vascular dysfunction: the nitric oxide connection.Akinsheye I, Klings ES.Akinsheye I, et al.J Cell Physiol. 2010 Sep;224(3):620-5. doi: 10.1002/jcp.22195.J Cell Physiol. 2010.PMID:20578237Review.
Cited by
- Intravascular hemolysis triggers ADP-mediated generation of platelet-rich thrombi in precapillary pulmonary arterioles.Brzoska T, Vats R, Bennewitz MF, Tutuncuoglu E, Watkins SC, Ragni MV, Neal MD, Gladwin MT, Sundd P.Brzoska T, et al.JCI Insight. 2020 Jul 23;5(14):e139437. doi: 10.1172/jci.insight.139437.JCI Insight. 2020.PMID:32544100Free PMC article.
- Pro-inflammatory Actions of Heme and Other Hemoglobin-Derived DAMPs.Bozza MT, Jeney V.Bozza MT, et al.Front Immunol. 2020 Jun 30;11:1323. doi: 10.3389/fimmu.2020.01323. eCollection 2020.Front Immunol. 2020.PMID:32695110Free PMC article.Review.
- A novel hemoglobin-binding peptide reduces cell-free hemoglobin in murine hemolytic anemia.Hanson MS, Xu H, Flewelen TC, Holzhauer SL, Retherford D, Jones DW, Frei AC, Pritchard KA Jr, Hillery CA, Hogg N, Wandersee NJ.Hanson MS, et al.Am J Physiol Heart Circ Physiol. 2013 Jan 15;304(2):H328-36. doi: 10.1152/ajpheart.00500.2012. Epub 2012 Nov 2.Am J Physiol Heart Circ Physiol. 2013.PMID:23125208Free PMC article.
- Acylsulfonamide-Functionalized Zwitterionic Gold Nanoparticles for Enhanced Cellular Uptake at Tumor pH.Mizuhara T, Saha K, Moyano DF, Kim CS, Yan B, Kim YK, Rotello VM.Mizuhara T, et al.Angew Chem Int Ed Engl. 2015 May 26;54(22):6567-70. doi: 10.1002/anie.201411615. Epub 2015 Apr 14.Angew Chem Int Ed Engl. 2015.PMID:25873209Free PMC article.
- Pulmonary hypertension in lambs transfused with stored blood is prevented by breathing nitric oxide.Baron DM, Yu B, Lei C, Bagchi A, Beloiartsev A, Stowell CP, Steinbicker AU, Malhotra R, Bloch KD, Zapol WM.Baron DM, et al.Anesthesiology. 2012 Mar;116(3):637-47. doi: 10.1097/ALN.0b013e318246ef77.Anesthesiology. 2012.PMID:22293717Free PMC article.
Publication types
MeSH terms
Substances
Related information
LinkOut - more resources
Full Text Sources
Other Literature Sources